» Authors » Simone Cazzaniga

Simone Cazzaniga

Explore the profile of Simone Cazzaniga including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 107
Citations 683
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Naldi L, Bettoli V, Santoro E, Valetto M, Bolzon A, Cassalia F, et al.
Dermatol Reports . 2025 Feb; PMID: 39969058
The large language model (LLM) ChatGPT can answer open-ended and complex questions, but its accuracy in providing reliable medical information requires a careful assessment. As part of the AICHECK (Artificial...
2.
Bettoli V, Naldi L, Santoro E, Valetto M, Bolzon A, Cassalia F, et al.
J Eur Acad Dermatol Venereol . 2024 Sep; PMID: 39282825
No abstract available.
3.
Georg P, Schmid M, Zahia S, Probst S, Cazzaniga S, Hunger R, et al.
J Clin Med . 2024 Jun; 13(12). PMID: 38930128
: Chronic leg ulcers present a global challenge in healthcare, necessitating precise wound measurement for effective treatment evaluation. This study is the first to validate the "split-wound design" approach for...
4.
Pezzolo E, Cazzaniga S, Cassalia F, Di Leo S, Naldi L
Arch Dermatol Res . 2024 May; 316(6):263. PMID: 38795124
No abstract available.
5.
Tutic-Sorrentino L, Cazzaniga S, Feldmeyer L, Benzaquen M
Clin Exp Dermatol . 2024 Apr; 49(10):1179-1185. PMID: 38624009
Background: Patients with melanoma present a high risk of developing extracutaneous metastases. Positron emission tomography--computed tomography (PET-CT) is one of the preferred examinations for the staging of oncological patients. It...
6.
Cassalia F, Cazzaniga S, Ofenloch R, Elsner P, Goncalo M, Schuttelaar M, et al.
Acta Derm Venereol . 2024 Mar; 104:adv23513. PMID: 38436432
Psoriasis, a chronic inflammatory skin disease, goes beyond visible symptoms and affects the general well-being of patients. The aim of this study is to understand how patients with psoriasis perceive...
7.
8.
Thormann K, Luthi A, Deniau F, Heider A, Cazzaniga S, Radonjic-Hoesli S, et al.
Allergy . 2024 Feb; 79(4):937-948. PMID: 38317432
Background: Dupilumab is used for the treatment of atopic dermatitis (AD). Approximately one third of AD patients develop a dupilumab-associated ocular surface disease (DAOSD), of which the pathomechanism is poorly...
9.
Vinay K, Kumar S, Dev A, Cazzaniga S, Borradori L, Thakur V, et al.
JAMA Dermatol . 2023 Dec; 160(1):80-87. PMID: 38055232
Importance: Symptomatic oral lichen planus (OLP) can be challenging to treat. Objective: To compare the efficacy of oral acitretin plus topical triamcinolone acetonide (TAC), 0.1%, with TAC monotherapy in patients...
10.
Cazzaniga S, Simon D
Br J Dermatol . 2023 Nov; 190(2):146-147. PMID: 37976182
No abstract available.